Stay updated on ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.

Latest updates to the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page
- Check4 days agoChange DetectedThe page shows a new site revision (Revision: v3.4.2) has been added, and the funding lapse notice along with Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check11 days agoChange DetectedAdded a site-wide government funding notice indicating possible delays and open status (cc.nih.gov and opm.gov references) and updated the system revision to v3.4.1, replacing the previous v3.4.0 note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check18 days agoChange DetectedShow glossary option added; capitalization tweaks for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; revision updated to v3.4.0.SummaryDifference0.2%

- Check32 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; no study content or key details appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded the Results section content for NCT02880956, including primary and secondary outcomes and safety/adverse events data.SummaryDifference0.1%

- Check54 days agoChange DetectedExpanded and reorganized the Locations section to include numerous new site locations across US states, Australia regions, Europe, and Canada, replacing the previous location groupings with updated regional entries.SummaryDifference2%

Stay in the know with updates to ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.